nodes	percent_of_prediction	percent_of_DWPC	metapath
Ribavirin—SLC28A3—Gemcitabine—urinary bladder cancer	0.19	0.448	CbGbCtD
Ribavirin—Cytarabine—Gemcitabine—urinary bladder cancer	0.173	0.513	CrCrCtD
Ribavirin—Azacitidine—Gemcitabine—urinary bladder cancer	0.165	0.487	CrCrCtD
Ribavirin—SLC29A1—Gemcitabine—urinary bladder cancer	0.126	0.298	CbGbCtD
Ribavirin—SLC29A1—Fluorouracil—urinary bladder cancer	0.108	0.254	CbGbCtD
Ribavirin—IMPDH1—Nucleotide Metabolism—POLB—urinary bladder cancer	0.00509	0.0926	CbGpPWpGaD
Ribavirin—ENPP1—prostate gland—urinary bladder cancer	0.00375	0.0698	CbGeAlD
Ribavirin—SLC28A3—prostate gland—urinary bladder cancer	0.0033	0.0613	CbGeAlD
Ribavirin—NT5C2—Purine catabolism—GPX1—urinary bladder cancer	0.00318	0.0578	CbGpPWpGaD
Ribavirin—IMPDH1—Nucleotide Metabolism—RRM2—urinary bladder cancer	0.00283	0.0515	CbGpPWpGaD
Ribavirin—NT5C2—prostate gland—urinary bladder cancer	0.00274	0.051	CbGeAlD
Ribavirin—ENPP1—renal system—urinary bladder cancer	0.00256	0.0476	CbGeAlD
Ribavirin—NT5C2—seminal vesicle—urinary bladder cancer	0.00232	0.0431	CbGeAlD
Ribavirin—IMPDH1—prostate gland—urinary bladder cancer	0.00223	0.0414	CbGeAlD
Ribavirin—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—GSTO2—urinary bladder cancer	0.00218	0.0395	CbGpPWpGaD
Ribavirin—ENPP1—female reproductive system—urinary bladder cancer	0.00205	0.0381	CbGeAlD
Ribavirin—ENPP1—Endochondral Ossification—HDAC4—urinary bladder cancer	0.00201	0.0365	CbGpPWpGaD
Ribavirin—NT5C2—smooth muscle tissue—urinary bladder cancer	0.00194	0.0361	CbGeAlD
Ribavirin—IMPDH1—seminal vesicle—urinary bladder cancer	0.00188	0.035	CbGeAlD
Ribavirin—NT5C2—renal system—urinary bladder cancer	0.00187	0.0347	CbGeAlD
Ribavirin—NT5C2—urethra—urinary bladder cancer	0.00184	0.0341	CbGeAlD
Ribavirin—ADK—prostate gland—urinary bladder cancer	0.00176	0.0326	CbGeAlD
Ribavirin—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—SLC19A1—urinary bladder cancer	0.00169	0.0307	CbGpPWpGaD
Ribavirin—Cytarabine—POLB—urinary bladder cancer	0.00167	0.418	CrCbGaD
Ribavirin—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—PRSS3—urinary bladder cancer	0.00165	0.03	CbGpPWpGaD
Ribavirin—SLC29A1—Fluoropyrimidine Activity—TYMP—urinary bladder cancer	0.00162	0.0294	CbGpPWpGaD
Ribavirin—IMPDH1—smooth muscle tissue—urinary bladder cancer	0.00158	0.0293	CbGeAlD
Ribavirin—IMPDH1—renal system—urinary bladder cancer	0.00152	0.0282	CbGeAlD
Ribavirin—NT5C2—female reproductive system—urinary bladder cancer	0.0015	0.0278	CbGeAlD
Ribavirin—SLC29A1—prostate gland—urinary bladder cancer	0.00149	0.0278	CbGeAlD
Ribavirin—IMPDH1—urethra—urinary bladder cancer	0.00149	0.0277	CbGeAlD
Ribavirin—ADK—seminal vesicle—urinary bladder cancer	0.00148	0.0276	CbGeAlD
Ribavirin—NT5C2—Nucleotide metabolism—TYMP—urinary bladder cancer	0.00144	0.0261	CbGpPWpGaD
Ribavirin—NT5C2—vagina—urinary bladder cancer	0.00135	0.0252	CbGeAlD
Ribavirin—SLC29A1—Fluoropyrimidine Activity—RRM2—urinary bladder cancer	0.00126	0.0229	CbGpPWpGaD
Ribavirin—ADK—smooth muscle tissue—urinary bladder cancer	0.00124	0.0231	CbGeAlD
Ribavirin—NT5C2—Purine metabolism—GPX1—urinary bladder cancer	0.00122	0.0222	CbGpPWpGaD
Ribavirin—IMPDH1—female reproductive system—urinary bladder cancer	0.00122	0.0226	CbGeAlD
Ribavirin—ENPP1—lymph node—urinary bladder cancer	0.0012	0.0223	CbGeAlD
Ribavirin—ADK—renal system—urinary bladder cancer	0.0012	0.0222	CbGeAlD
Ribavirin—ADK—urethra—urinary bladder cancer	0.00118	0.0218	CbGeAlD
Ribavirin—IMPDH1—Nucleotide metabolism—TYMP—urinary bladder cancer	0.00117	0.0213	CbGpPWpGaD
Ribavirin—NT5C2—Nucleotide metabolism—RRM2—urinary bladder cancer	0.00112	0.0204	CbGpPWpGaD
Ribavirin—IMPDH1—vagina—urinary bladder cancer	0.0011	0.0204	CbGeAlD
Ribavirin—ADK—Nucleotide metabolism—TYMP—urinary bladder cancer	0.00109	0.0198	CbGpPWpGaD
Ribavirin—Clofarabine—RRM2—urinary bladder cancer	0.00107	0.266	CrCbGaD
Ribavirin—SLC29A1—renal system—urinary bladder cancer	0.00102	0.0189	CbGeAlD
Ribavirin—SLC29A1—urethra—urinary bladder cancer	0.001	0.0186	CbGeAlD
Ribavirin—IMPDH1—Purine metabolism—GPX1—urinary bladder cancer	0.000998	0.0181	CbGpPWpGaD
Ribavirin—ADK—female reproductive system—urinary bladder cancer	0.000958	0.0178	CbGeAlD
Ribavirin—ADK—Purine metabolism—GPX1—urinary bladder cancer	0.000928	0.0169	CbGpPWpGaD
Ribavirin—IMPDH1—Nucleotide metabolism—RRM2—urinary bladder cancer	0.000916	0.0166	CbGpPWpGaD
Ribavirin—NT5C2—lymph node—urinary bladder cancer	0.000876	0.0163	CbGeAlD
Ribavirin—ADK—vagina—urinary bladder cancer	0.000867	0.0161	CbGeAlD
Ribavirin—ADK—Nucleotide metabolism—RRM2—urinary bladder cancer	0.000851	0.0155	CbGpPWpGaD
Ribavirin—SLC29A1—female reproductive system—urinary bladder cancer	0.000816	0.0152	CbGeAlD
Ribavirin—SLC29A1—vagina—urinary bladder cancer	0.000738	0.0137	CbGeAlD
Ribavirin—SLC29A1—Fluoropyrimidine Activity—TYMS—urinary bladder cancer	0.000731	0.0133	CbGpPWpGaD
Ribavirin—IMPDH1—lymph node—urinary bladder cancer	0.000711	0.0132	CbGeAlD
Ribavirin—SLC28A3—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.000687	0.0125	CbGpPWpGaD
Ribavirin—SLC29A1—Fluoropyrimidine Activity—ERCC2—urinary bladder cancer	0.000679	0.0123	CbGpPWpGaD
Ribavirin—NT5C2—Nucleotide metabolism—TYMS—urinary bladder cancer	0.00065	0.0118	CbGpPWpGaD
Ribavirin—SLC29A1—Fluoropyrimidine Activity—MTHFR—urinary bladder cancer	0.000639	0.0116	CbGpPWpGaD
Ribavirin—ENPP1—Endochondral Ossification—PLAU—urinary bladder cancer	0.000628	0.0114	CbGpPWpGaD
Ribavirin—NT5C2—Nucleotide metabolism—GPX1—urinary bladder cancer	0.000615	0.0112	CbGpPWpGaD
Ribavirin—ENPP1—Endochondral Ossification—FGFR3—urinary bladder cancer	0.000609	0.0111	CbGpPWpGaD
Ribavirin—ADK—lymph node—urinary bladder cancer	0.000561	0.0104	CbGeAlD
Ribavirin—Glucosamine—MMP9—urinary bladder cancer	0.000552	0.138	CrCbGaD
Ribavirin—IMPDH1—Nucleotide metabolism—TYMS—urinary bladder cancer	0.00053	0.00963	CbGpPWpGaD
Ribavirin—ENPP1—Insulin Signaling—TSC1—urinary bladder cancer	0.000522	0.00948	CbGpPWpGaD
Ribavirin—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—urinary bladder cancer	0.00052	0.00945	CbGpPWpGaD
Ribavirin—SLC29A1—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.000512	0.0093	CbGpPWpGaD
Ribavirin—ENPP1—Endochondral Ossification—IGF1—urinary bladder cancer	0.000512	0.0093	CbGpPWpGaD
Ribavirin—IMPDH1—Nucleotide metabolism—GPX1—urinary bladder cancer	0.000502	0.00911	CbGpPWpGaD
Ribavirin—ADK—Nucleotide metabolism—TYMS—urinary bladder cancer	0.000493	0.00895	CbGpPWpGaD
Ribavirin—SLC29A1—lymph node—urinary bladder cancer	0.000477	0.00887	CbGeAlD
Ribavirin—ADK—Nucleotide metabolism—GPX1—urinary bladder cancer	0.000466	0.00847	CbGpPWpGaD
Ribavirin—ENPP1—Endochondral Ossification—MMP9—urinary bladder cancer	0.000372	0.00676	CbGpPWpGaD
Ribavirin—Glucosamine—TNF—urinary bladder cancer	0.000363	0.0907	CrCbGaD
Ribavirin—Adenosine monophosphate—SRC—urinary bladder cancer	0.00035	0.0875	CrCbGaD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000349	0.00634	CbGpPWpGaD
Ribavirin—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—urinary bladder cancer	0.000332	0.00603	CbGpPWpGaD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.00026	0.00473	CbGpPWpGaD
Ribavirin—ENPP1—Disease—GSTO2—urinary bladder cancer	0.000258	0.00468	CbGpPWpGaD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000252	0.00458	CbGpPWpGaD
Ribavirin—SLC29A1—Fluoropyrimidine Activity—TP53—urinary bladder cancer	0.000242	0.00441	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—GSTZ1—urinary bladder cancer	0.000228	0.00413	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—GSTZ1—urinary bladder cancer	0.000228	0.00413	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—GSTO2—urinary bladder cancer	0.000216	0.00392	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—NAT1—urinary bladder cancer	0.000216	0.00392	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—NAT1—urinary bladder cancer	0.000216	0.00392	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—GSTO2—urinary bladder cancer	0.000216	0.00392	CbGpPWpGaD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000206	0.00374	CbGpPWpGaD
Ribavirin—ENPP1—Disease—SLC19A1—urinary bladder cancer	0.0002	0.00364	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—UGT2B7—urinary bladder cancer	0.000197	0.00358	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—UGT2B7—urinary bladder cancer	0.000197	0.00358	CbGpPWpGaD
Ribavirin—ENPP1—Disease—PRSS3—urinary bladder cancer	0.000195	0.00355	CbGpPWpGaD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000188	0.00342	CbGpPWpGaD
Ribavirin—ENPP1—Disease—HDAC4—urinary bladder cancer	0.000186	0.00338	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—GSTZ1—urinary bladder cancer	0.000185	0.00337	CbGpPWpGaD
Ribavirin—ENPP1—Insulin Signaling—PTEN—urinary bladder cancer	0.000178	0.00323	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—CYP4B1—urinary bladder cancer	0.000178	0.00323	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—CYP4B1—urinary bladder cancer	0.000178	0.00323	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—GSTO2—urinary bladder cancer	0.000176	0.00319	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—NAT1—urinary bladder cancer	0.000176	0.00319	CbGpPWpGaD
Ribavirin—ADK—Metabolism—GSTZ1—urinary bladder cancer	0.000172	0.00313	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—SLC19A1—urinary bladder cancer	0.000168	0.00305	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—SLC19A1—urinary bladder cancer	0.000168	0.00305	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—PRSS3—urinary bladder cancer	0.000163	0.00297	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—PRSS3—urinary bladder cancer	0.000163	0.00297	CbGpPWpGaD
Ribavirin—ADK—Metabolism—GSTO2—urinary bladder cancer	0.000163	0.00297	CbGpPWpGaD
Ribavirin—ADK—Metabolism—NAT1—urinary bladder cancer	0.000163	0.00297	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—UGT2B7—urinary bladder cancer	0.000161	0.00292	CbGpPWpGaD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000153	0.00279	CbGpPWpGaD
Ribavirin—ADK—Metabolism—UGT2B7—urinary bladder cancer	0.00015	0.00272	CbGpPWpGaD
Ribavirin—ENPP1—Disease—LIG1—urinary bladder cancer	0.000148	0.00269	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—CYP4B1—urinary bladder cancer	0.000145	0.00263	CbGpPWpGaD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000139	0.00252	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—SLC19A1—urinary bladder cancer	0.000137	0.00248	CbGpPWpGaD
Ribavirin—ADK—Metabolism—CYP4B1—urinary bladder cancer	0.000135	0.00245	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—PRSS3—urinary bladder cancer	0.000133	0.00242	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—TYMP—urinary bladder cancer	0.000131	0.00237	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—TYMP—urinary bladder cancer	0.000131	0.00237	CbGpPWpGaD
Ribavirin—ADK—Metabolism—SLC19A1—urinary bladder cancer	0.000127	0.00231	CbGpPWpGaD
Ribavirin—ADK—Metabolism—PRSS3—urinary bladder cancer	0.000124	0.00225	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—NAT2—urinary bladder cancer	0.000118	0.00215	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—NAT2—urinary bladder cancer	0.000118	0.00215	CbGpPWpGaD
Ribavirin—ENPP1—Insulin Signaling—HRAS—urinary bladder cancer	0.000116	0.00211	CbGpPWpGaD
Ribavirin—ENPP1—Disease—ENO2—urinary bladder cancer	0.000113	0.00205	CbGpPWpGaD
Ribavirin—ENPP1—Disease—RBX1—urinary bladder cancer	0.000107	0.00194	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—TYMP—urinary bladder cancer	0.000107	0.00194	CbGpPWpGaD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000104	0.00188	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—RRM2—urinary bladder cancer	0.000102	0.00185	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—RRM2—urinary bladder cancer	0.000102	0.00185	CbGpPWpGaD
Ribavirin—ADK—Metabolism—TYMP—urinary bladder cancer	9.9e-05	0.0018	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—NAT2—urinary bladder cancer	9.63e-05	0.00175	CbGpPWpGaD
Ribavirin—ENPP1—Disease—JAG1—urinary bladder cancer	9.57e-05	0.00174	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—HPGDS—urinary bladder cancer	9.45e-05	0.00172	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—ENO2—urinary bladder cancer	9.45e-05	0.00172	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—ENO2—urinary bladder cancer	9.45e-05	0.00172	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—HPGDS—urinary bladder cancer	9.45e-05	0.00172	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—GSTT1—urinary bladder cancer	9.16e-05	0.00167	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—GSTT1—urinary bladder cancer	9.16e-05	0.00167	CbGpPWpGaD
Ribavirin—ADK—Metabolism—NAT2—urinary bladder cancer	8.96e-05	0.00163	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—RRM2—urinary bladder cancer	8.32e-05	0.00151	CbGpPWpGaD
Ribavirin—ADK—Metabolism—RRM2—urinary bladder cancer	7.73e-05	0.0014	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—HPGDS—urinary bladder cancer	7.7e-05	0.0014	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—ENO2—urinary bladder cancer	7.7e-05	0.0014	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—NQO1—urinary bladder cancer	7.62e-05	0.00138	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—NQO1—urinary bladder cancer	7.62e-05	0.00138	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—GSTT1—urinary bladder cancer	7.47e-05	0.00136	CbGpPWpGaD
Ribavirin—ADK—Metabolism—HPGDS—urinary bladder cancer	7.16e-05	0.0013	CbGpPWpGaD
Ribavirin—ADK—Metabolism—ENO2—urinary bladder cancer	7.16e-05	0.0013	CbGpPWpGaD
Ribavirin—ENPP1—Disease—NCOR1—urinary bladder cancer	6.97e-05	0.00127	CbGpPWpGaD
Ribavirin—ADK—Metabolism—GSTT1—urinary bladder cancer	6.94e-05	0.00126	CbGpPWpGaD
Ribavirin—ENPP1—Disease—ERCC2—urinary bladder cancer	6.55e-05	0.00119	CbGpPWpGaD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.5e-05	0.00118	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—GSTP1—urinary bladder cancer	6.35e-05	0.00115	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—GSTP1—urinary bladder cancer	6.35e-05	0.00115	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—NQO1—urinary bladder cancer	6.21e-05	0.00113	CbGpPWpGaD
Ribavirin—ENPP1—Disease—MTHFR—urinary bladder cancer	6.16e-05	0.00112	CbGpPWpGaD
Ribavirin—ENPP1—Disease—TERT—urinary bladder cancer	6.14e-05	0.00112	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—TYMS—urinary bladder cancer	5.91e-05	0.00107	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—TYMS—urinary bladder cancer	5.91e-05	0.00107	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—NCOR1—urinary bladder cancer	5.84e-05	0.00106	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—GSTM1—urinary bladder cancer	5.84e-05	0.00106	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—GSTM1—urinary bladder cancer	5.84e-05	0.00106	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—NCOR1—urinary bladder cancer	5.84e-05	0.00106	CbGpPWpGaD
Ribavirin—ADK—Metabolism—NQO1—urinary bladder cancer	5.77e-05	0.00105	CbGpPWpGaD
Ribavirin—ENPP1—Disease—FGFR3—urinary bladder cancer	5.64e-05	0.00102	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—GPX1—urinary bladder cancer	5.59e-05	0.00102	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—GPX1—urinary bladder cancer	5.59e-05	0.00102	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—ERCC2—urinary bladder cancer	5.49e-05	0.000997	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—ERCC2—urinary bladder cancer	5.49e-05	0.000997	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—GSTP1—urinary bladder cancer	5.18e-05	0.000941	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—MTHFR—urinary bladder cancer	5.16e-05	0.000937	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—MTHFR—urinary bladder cancer	5.16e-05	0.000937	CbGpPWpGaD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.85e-05	0.000881	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—TYMS—urinary bladder cancer	4.81e-05	0.000875	CbGpPWpGaD
Ribavirin—ADK—Metabolism—GSTP1—urinary bladder cancer	4.81e-05	0.000875	CbGpPWpGaD
Ribavirin—ENPP1—Disease—CREBBP—urinary bladder cancer	4.8e-05	0.000872	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—NCOR1—urinary bladder cancer	4.76e-05	0.000865	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—GSTM1—urinary bladder cancer	4.76e-05	0.000865	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—GPX1—urinary bladder cancer	4.56e-05	0.000828	CbGpPWpGaD
Ribavirin—ADK—Metabolism—TYMS—urinary bladder cancer	4.48e-05	0.000813	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—ERCC2—urinary bladder cancer	4.47e-05	0.000813	CbGpPWpGaD
Ribavirin—ADK—Metabolism—NCOR1—urinary bladder cancer	4.42e-05	0.000804	CbGpPWpGaD
Ribavirin—ADK—Metabolism—GSTM1—urinary bladder cancer	4.42e-05	0.000804	CbGpPWpGaD
Ribavirin—ENPP1—Disease—RHOA—urinary bladder cancer	4.34e-05	0.000789	CbGpPWpGaD
Ribavirin—ADK—Metabolism—GPX1—urinary bladder cancer	4.24e-05	0.00077	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—MTHFR—urinary bladder cancer	4.21e-05	0.000764	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—PPARG—urinary bladder cancer	4.18e-05	0.00076	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—PPARG—urinary bladder cancer	4.18e-05	0.00076	CbGpPWpGaD
Ribavirin—ADK—Metabolism—ERCC2—urinary bladder cancer	4.16e-05	0.000756	CbGpPWpGaD
Ribavirin—Angiopathy—Methotrexate—urinary bladder cancer	4.09e-05	0.00033	CcSEcCtD
Ribavirin—Sinusitis—Doxorubicin—urinary bladder cancer	4.08e-05	0.000329	CcSEcCtD
Ribavirin—Immune system disorder—Methotrexate—urinary bladder cancer	4.07e-05	0.000329	CcSEcCtD
Ribavirin—Dizziness—Fluorouracil—urinary bladder cancer	4.07e-05	0.000329	CcSEcCtD
Ribavirin—Visual impairment—Epirubicin—urinary bladder cancer	4.06e-05	0.000328	CcSEcCtD
Ribavirin—Mediastinal disorder—Methotrexate—urinary bladder cancer	4.06e-05	0.000328	CcSEcCtD
Ribavirin—Chills—Methotrexate—urinary bladder cancer	4.04e-05	0.000326	CcSEcCtD
Ribavirin—ENPP1—Metabolism—CREBBP—urinary bladder cancer	4.02e-05	0.00073	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—CREBBP—urinary bladder cancer	4.02e-05	0.00073	CbGpPWpGaD
Ribavirin—ENPP1—Disease—ERBB2—urinary bladder cancer	4.02e-05	0.00073	CbGpPWpGaD
Ribavirin—Diarrhoea—Cisplatin—urinary bladder cancer	3.99e-05	0.000322	CcSEcCtD
Ribavirin—Erythema multiforme—Epirubicin—urinary bladder cancer	3.99e-05	0.000322	CcSEcCtD
Ribavirin—Alopecia—Methotrexate—urinary bladder cancer	3.98e-05	0.000322	CcSEcCtD
Ribavirin—Vomiting—Gemcitabine—urinary bladder cancer	3.98e-05	0.000321	CcSEcCtD
Ribavirin—Bradycardia—Doxorubicin—urinary bladder cancer	3.97e-05	0.000321	CcSEcCtD
Ribavirin—Mental disorder—Methotrexate—urinary bladder cancer	3.95e-05	0.000319	CcSEcCtD
Ribavirin—Rash—Gemcitabine—urinary bladder cancer	3.95e-05	0.000319	CcSEcCtD
Ribavirin—Dermatitis—Gemcitabine—urinary bladder cancer	3.94e-05	0.000318	CcSEcCtD
Ribavirin—Eye disorder—Epirubicin—urinary bladder cancer	3.94e-05	0.000318	CcSEcCtD
Ribavirin—Hypersensitivity—Etoposide—urinary bladder cancer	3.94e-05	0.000318	CcSEcCtD
Ribavirin—Tinnitus—Epirubicin—urinary bladder cancer	3.93e-05	0.000317	CcSEcCtD
Ribavirin—ENPP1—Disease—PTGS2—urinary bladder cancer	3.93e-05	0.000714	CbGpPWpGaD
Ribavirin—Erythema—Methotrexate—urinary bladder cancer	3.92e-05	0.000317	CcSEcCtD
Ribavirin—Malnutrition—Methotrexate—urinary bladder cancer	3.92e-05	0.000317	CcSEcCtD
Ribavirin—Haemoglobin—Doxorubicin—urinary bladder cancer	3.92e-05	0.000317	CcSEcCtD
Ribavirin—Headache—Gemcitabine—urinary bladder cancer	3.92e-05	0.000317	CcSEcCtD
Ribavirin—Cardiac disorder—Epirubicin—urinary bladder cancer	3.91e-05	0.000316	CcSEcCtD
Ribavirin—Flushing—Epirubicin—urinary bladder cancer	3.91e-05	0.000316	CcSEcCtD
Ribavirin—Vomiting—Fluorouracil—urinary bladder cancer	3.91e-05	0.000316	CcSEcCtD
Ribavirin—Rhinitis—Doxorubicin—urinary bladder cancer	3.91e-05	0.000316	CcSEcCtD
Ribavirin—ADK—Metabolism—MTHFR—urinary bladder cancer	3.91e-05	0.00071	CbGpPWpGaD
Ribavirin—Haemorrhage—Doxorubicin—urinary bladder cancer	3.9e-05	0.000315	CcSEcCtD
Ribavirin—Hepatitis—Doxorubicin—urinary bladder cancer	3.9e-05	0.000315	CcSEcCtD
Ribavirin—Hypoaesthesia—Doxorubicin—urinary bladder cancer	3.88e-05	0.000313	CcSEcCtD
Ribavirin—Rash—Fluorouracil—urinary bladder cancer	3.88e-05	0.000313	CcSEcCtD
Ribavirin—Dermatitis—Fluorouracil—urinary bladder cancer	3.88e-05	0.000313	CcSEcCtD
Ribavirin—Pharyngitis—Doxorubicin—urinary bladder cancer	3.87e-05	0.000313	CcSEcCtD
Ribavirin—Headache—Fluorouracil—urinary bladder cancer	3.86e-05	0.000311	CcSEcCtD
Ribavirin—Urinary tract disorder—Doxorubicin—urinary bladder cancer	3.85e-05	0.000311	CcSEcCtD
Ribavirin—Oedema peripheral—Doxorubicin—urinary bladder cancer	3.84e-05	0.00031	CcSEcCtD
Ribavirin—Dysgeusia—Methotrexate—urinary bladder cancer	3.84e-05	0.00031	CcSEcCtD
Ribavirin—Asthenia—Etoposide—urinary bladder cancer	3.83e-05	0.00031	CcSEcCtD
Ribavirin—Connective tissue disorder—Doxorubicin—urinary bladder cancer	3.83e-05	0.00031	CcSEcCtD
Ribavirin—Angiopathy—Epirubicin—urinary bladder cancer	3.83e-05	0.000309	CcSEcCtD
Ribavirin—Urethral disorder—Doxorubicin—urinary bladder cancer	3.82e-05	0.000309	CcSEcCtD
Ribavirin—Immune system disorder—Epirubicin—urinary bladder cancer	3.81e-05	0.000308	CcSEcCtD
Ribavirin—Mediastinal disorder—Epirubicin—urinary bladder cancer	3.8e-05	0.000307	CcSEcCtD
Ribavirin—Back pain—Methotrexate—urinary bladder cancer	3.79e-05	0.000306	CcSEcCtD
Ribavirin—Chills—Epirubicin—urinary bladder cancer	3.78e-05	0.000306	CcSEcCtD
Ribavirin—Pruritus—Etoposide—urinary bladder cancer	3.78e-05	0.000305	CcSEcCtD
Ribavirin—Arrhythmia—Epirubicin—urinary bladder cancer	3.77e-05	0.000304	CcSEcCtD
Ribavirin—Visual impairment—Doxorubicin—urinary bladder cancer	3.76e-05	0.000304	CcSEcCtD
Ribavirin—Alopecia—Epirubicin—urinary bladder cancer	3.73e-05	0.000301	CcSEcCtD
Ribavirin—Nausea—Gemcitabine—urinary bladder cancer	3.72e-05	0.0003	CcSEcCtD
Ribavirin—Vomiting—Cisplatin—urinary bladder cancer	3.71e-05	0.000299	CcSEcCtD
Ribavirin—Vision blurred—Methotrexate—urinary bladder cancer	3.7e-05	0.000298	CcSEcCtD
Ribavirin—Mental disorder—Epirubicin—urinary bladder cancer	3.69e-05	0.000298	CcSEcCtD
Ribavirin—Erythema multiforme—Doxorubicin—urinary bladder cancer	3.69e-05	0.000298	CcSEcCtD
Ribavirin—Rash—Cisplatin—urinary bladder cancer	3.68e-05	0.000297	CcSEcCtD
Ribavirin—Dermatitis—Cisplatin—urinary bladder cancer	3.68e-05	0.000297	CcSEcCtD
Ribavirin—Malnutrition—Epirubicin—urinary bladder cancer	3.67e-05	0.000296	CcSEcCtD
Ribavirin—Erythema—Epirubicin—urinary bladder cancer	3.67e-05	0.000296	CcSEcCtD
Ribavirin—Diarrhoea—Etoposide—urinary bladder cancer	3.66e-05	0.000295	CcSEcCtD
Ribavirin—Nausea—Fluorouracil—urinary bladder cancer	3.66e-05	0.000295	CcSEcCtD
Ribavirin—Eye disorder—Doxorubicin—urinary bladder cancer	3.65e-05	0.000294	CcSEcCtD
Ribavirin—Ill-defined disorder—Methotrexate—urinary bladder cancer	3.64e-05	0.000294	CcSEcCtD
Ribavirin—Tinnitus—Doxorubicin—urinary bladder cancer	3.64e-05	0.000294	CcSEcCtD
Ribavirin—Anaemia—Methotrexate—urinary bladder cancer	3.63e-05	0.000293	CcSEcCtD
Ribavirin—Cardiac disorder—Doxorubicin—urinary bladder cancer	3.62e-05	0.000292	CcSEcCtD
Ribavirin—Flushing—Doxorubicin—urinary bladder cancer	3.62e-05	0.000292	CcSEcCtD
Ribavirin—Flatulence—Epirubicin—urinary bladder cancer	3.62e-05	0.000292	CcSEcCtD
Ribavirin—Tension—Epirubicin—urinary bladder cancer	3.6e-05	0.000291	CcSEcCtD
Ribavirin—Dysgeusia—Epirubicin—urinary bladder cancer	3.59e-05	0.00029	CcSEcCtD
Ribavirin—Nervousness—Epirubicin—urinary bladder cancer	3.57e-05	0.000288	CcSEcCtD
Ribavirin—Back pain—Epirubicin—urinary bladder cancer	3.55e-05	0.000287	CcSEcCtD
Ribavirin—Angiopathy—Doxorubicin—urinary bladder cancer	3.54e-05	0.000286	CcSEcCtD
Ribavirin—Malaise—Methotrexate—urinary bladder cancer	3.54e-05	0.000286	CcSEcCtD
Ribavirin—Dizziness—Etoposide—urinary bladder cancer	3.53e-05	0.000285	CcSEcCtD
Ribavirin—Muscle spasms—Epirubicin—urinary bladder cancer	3.53e-05	0.000285	CcSEcCtD
Ribavirin—Immune system disorder—Doxorubicin—urinary bladder cancer	3.52e-05	0.000285	CcSEcCtD
Ribavirin—Vertigo—Methotrexate—urinary bladder cancer	3.52e-05	0.000285	CcSEcCtD
Ribavirin—Mediastinal disorder—Doxorubicin—urinary bladder cancer	3.52e-05	0.000284	CcSEcCtD
Ribavirin—Leukopenia—Methotrexate—urinary bladder cancer	3.51e-05	0.000284	CcSEcCtD
Ribavirin—Chills—Doxorubicin—urinary bladder cancer	3.5e-05	0.000283	CcSEcCtD
Ribavirin—Arrhythmia—Doxorubicin—urinary bladder cancer	3.49e-05	0.000281	CcSEcCtD
Ribavirin—Nausea—Cisplatin—urinary bladder cancer	3.47e-05	0.00028	CcSEcCtD
Ribavirin—Vision blurred—Epirubicin—urinary bladder cancer	3.46e-05	0.000279	CcSEcCtD
Ribavirin—Alopecia—Doxorubicin—urinary bladder cancer	3.45e-05	0.000278	CcSEcCtD
Ribavirin—ENPP1—Disease—CDKN1A—urinary bladder cancer	3.43e-05	0.000624	CbGpPWpGaD
Ribavirin—ENPP1—Disease—PTEN—urinary bladder cancer	3.43e-05	0.000623	CbGpPWpGaD
Ribavirin—Cough—Methotrexate—urinary bladder cancer	3.42e-05	0.000276	CcSEcCtD
Ribavirin—Mental disorder—Doxorubicin—urinary bladder cancer	3.42e-05	0.000276	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—PPARG—urinary bladder cancer	3.41e-05	0.00062	CbGpPWpGaD
Ribavirin—Ill-defined disorder—Epirubicin—urinary bladder cancer	3.41e-05	0.000275	CcSEcCtD
Ribavirin—Convulsion—Methotrexate—urinary bladder cancer	3.4e-05	0.000274	CcSEcCtD
Ribavirin—Vomiting—Etoposide—urinary bladder cancer	3.4e-05	0.000274	CcSEcCtD
Ribavirin—Erythema—Doxorubicin—urinary bladder cancer	3.4e-05	0.000274	CcSEcCtD
Ribavirin—Malnutrition—Doxorubicin—urinary bladder cancer	3.4e-05	0.000274	CcSEcCtD
Ribavirin—Anaemia—Epirubicin—urinary bladder cancer	3.39e-05	0.000274	CcSEcCtD
Ribavirin—Agitation—Epirubicin—urinary bladder cancer	3.37e-05	0.000272	CcSEcCtD
Ribavirin—Rash—Etoposide—urinary bladder cancer	3.37e-05	0.000272	CcSEcCtD
Ribavirin—Dermatitis—Etoposide—urinary bladder cancer	3.37e-05	0.000272	CcSEcCtD
Ribavirin—Headache—Etoposide—urinary bladder cancer	3.35e-05	0.00027	CcSEcCtD
Ribavirin—Flatulence—Doxorubicin—urinary bladder cancer	3.35e-05	0.00027	CcSEcCtD
Ribavirin—Chest pain—Methotrexate—urinary bladder cancer	3.34e-05	0.00027	CcSEcCtD
Ribavirin—Myalgia—Methotrexate—urinary bladder cancer	3.34e-05	0.00027	CcSEcCtD
Ribavirin—Arthralgia—Methotrexate—urinary bladder cancer	3.34e-05	0.00027	CcSEcCtD
Ribavirin—Tension—Doxorubicin—urinary bladder cancer	3.33e-05	0.000269	CcSEcCtD
Ribavirin—Dysgeusia—Doxorubicin—urinary bladder cancer	3.33e-05	0.000269	CcSEcCtD
Ribavirin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	3.32e-05	0.000268	CcSEcCtD
Ribavirin—Malaise—Epirubicin—urinary bladder cancer	3.31e-05	0.000267	CcSEcCtD
Ribavirin—Discomfort—Methotrexate—urinary bladder cancer	3.3e-05	0.000266	CcSEcCtD
Ribavirin—Nervousness—Doxorubicin—urinary bladder cancer	3.3e-05	0.000266	CcSEcCtD
Ribavirin—Vertigo—Epirubicin—urinary bladder cancer	3.3e-05	0.000266	CcSEcCtD
Ribavirin—Syncope—Epirubicin—urinary bladder cancer	3.29e-05	0.000266	CcSEcCtD
Ribavirin—ENPP1—Metabolism—PTGS2—urinary bladder cancer	3.29e-05	0.000598	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—PTGS2—urinary bladder cancer	3.29e-05	0.000598	CbGpPWpGaD
Ribavirin—Leukopenia—Epirubicin—urinary bladder cancer	3.29e-05	0.000265	CcSEcCtD
Ribavirin—Back pain—Doxorubicin—urinary bladder cancer	3.29e-05	0.000265	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—CREBBP—urinary bladder cancer	3.28e-05	0.000595	CbGpPWpGaD
Ribavirin—ENPP1—Disease—EP300—urinary bladder cancer	3.27e-05	0.000594	CbGpPWpGaD
Ribavirin—Muscle spasms—Doxorubicin—urinary bladder cancer	3.27e-05	0.000264	CcSEcCtD
Ribavirin—Palpitations—Epirubicin—urinary bladder cancer	3.24e-05	0.000262	CcSEcCtD
Ribavirin—Confusional state—Methotrexate—urinary bladder cancer	3.23e-05	0.000261	CcSEcCtD
Ribavirin—Loss of consciousness—Epirubicin—urinary bladder cancer	3.23e-05	0.000261	CcSEcCtD
Ribavirin—Cough—Epirubicin—urinary bladder cancer	3.2e-05	0.000259	CcSEcCtD
Ribavirin—Anaphylactic shock—Methotrexate—urinary bladder cancer	3.2e-05	0.000258	CcSEcCtD
Ribavirin—Vision blurred—Doxorubicin—urinary bladder cancer	3.2e-05	0.000258	CcSEcCtD
Ribavirin—Convulsion—Epirubicin—urinary bladder cancer	3.18e-05	0.000257	CcSEcCtD
Ribavirin—ENPP1—Disease—SRC—urinary bladder cancer	3.18e-05	0.000577	CbGpPWpGaD
Ribavirin—Nausea—Etoposide—urinary bladder cancer	3.17e-05	0.000256	CcSEcCtD
Ribavirin—ADK—Metabolism—PPARG—urinary bladder cancer	3.17e-05	0.000576	CbGpPWpGaD
Ribavirin—Hypertension—Epirubicin—urinary bladder cancer	3.17e-05	0.000256	CcSEcCtD
Ribavirin—Ill-defined disorder—Doxorubicin—urinary bladder cancer	3.15e-05	0.000254	CcSEcCtD
Ribavirin—Nervous system disorder—Methotrexate—urinary bladder cancer	3.14e-05	0.000253	CcSEcCtD
Ribavirin—Anaemia—Doxorubicin—urinary bladder cancer	3.14e-05	0.000253	CcSEcCtD
Ribavirin—Thrombocytopenia—Methotrexate—urinary bladder cancer	3.13e-05	0.000253	CcSEcCtD
Ribavirin—Arthralgia—Epirubicin—urinary bladder cancer	3.13e-05	0.000252	CcSEcCtD
Ribavirin—Myalgia—Epirubicin—urinary bladder cancer	3.13e-05	0.000252	CcSEcCtD
Ribavirin—Chest pain—Epirubicin—urinary bladder cancer	3.13e-05	0.000252	CcSEcCtD
Ribavirin—Agitation—Doxorubicin—urinary bladder cancer	3.12e-05	0.000252	CcSEcCtD
Ribavirin—Anxiety—Epirubicin—urinary bladder cancer	3.11e-05	0.000251	CcSEcCtD
Ribavirin—Skin disorder—Methotrexate—urinary bladder cancer	3.11e-05	0.000251	CcSEcCtD
Ribavirin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	3.1e-05	0.000251	CcSEcCtD
Ribavirin—Hyperhidrosis—Methotrexate—urinary bladder cancer	3.09e-05	0.00025	CcSEcCtD
Ribavirin—Discomfort—Epirubicin—urinary bladder cancer	3.09e-05	0.000249	CcSEcCtD
Ribavirin—Malaise—Doxorubicin—urinary bladder cancer	3.06e-05	0.000247	CcSEcCtD
Ribavirin—Dry mouth—Epirubicin—urinary bladder cancer	3.06e-05	0.000247	CcSEcCtD
Ribavirin—Vertigo—Doxorubicin—urinary bladder cancer	3.05e-05	0.000246	CcSEcCtD
Ribavirin—Anorexia—Methotrexate—urinary bladder cancer	3.05e-05	0.000246	CcSEcCtD
Ribavirin—Syncope—Doxorubicin—urinary bladder cancer	3.05e-05	0.000246	CcSEcCtD
Ribavirin—ADK—Metabolism—CREBBP—urinary bladder cancer	3.05e-05	0.000553	CbGpPWpGaD
Ribavirin—Leukopenia—Doxorubicin—urinary bladder cancer	3.04e-05	0.000245	CcSEcCtD
Ribavirin—Confusional state—Epirubicin—urinary bladder cancer	3.02e-05	0.000244	CcSEcCtD
Ribavirin—Palpitations—Doxorubicin—urinary bladder cancer	3e-05	0.000242	CcSEcCtD
Ribavirin—Oedema—Epirubicin—urinary bladder cancer	3e-05	0.000242	CcSEcCtD
Ribavirin—Anaphylactic shock—Epirubicin—urinary bladder cancer	3e-05	0.000242	CcSEcCtD
Ribavirin—Hypotension—Methotrexate—urinary bladder cancer	2.99e-05	0.000242	CcSEcCtD
Ribavirin—Loss of consciousness—Doxorubicin—urinary bladder cancer	2.99e-05	0.000241	CcSEcCtD
Ribavirin—Cough—Doxorubicin—urinary bladder cancer	2.96e-05	0.000239	CcSEcCtD
Ribavirin—Shock—Epirubicin—urinary bladder cancer	2.95e-05	0.000238	CcSEcCtD
Ribavirin—Convulsion—Doxorubicin—urinary bladder cancer	2.94e-05	0.000238	CcSEcCtD
Ribavirin—Nervous system disorder—Epirubicin—urinary bladder cancer	2.94e-05	0.000237	CcSEcCtD
Ribavirin—Thrombocytopenia—Epirubicin—urinary bladder cancer	2.93e-05	0.000237	CcSEcCtD
Ribavirin—Hypertension—Doxorubicin—urinary bladder cancer	2.93e-05	0.000237	CcSEcCtD
Ribavirin—Tachycardia—Epirubicin—urinary bladder cancer	2.92e-05	0.000236	CcSEcCtD
Ribavirin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	2.92e-05	0.000236	CcSEcCtD
Ribavirin—Skin disorder—Epirubicin—urinary bladder cancer	2.91e-05	0.000235	CcSEcCtD
Ribavirin—Hyperhidrosis—Epirubicin—urinary bladder cancer	2.9e-05	0.000234	CcSEcCtD
Ribavirin—Insomnia—Methotrexate—urinary bladder cancer	2.9e-05	0.000234	CcSEcCtD
Ribavirin—Arthralgia—Doxorubicin—urinary bladder cancer	2.89e-05	0.000233	CcSEcCtD
Ribavirin—Chest pain—Doxorubicin—urinary bladder cancer	2.89e-05	0.000233	CcSEcCtD
Ribavirin—Myalgia—Doxorubicin—urinary bladder cancer	2.89e-05	0.000233	CcSEcCtD
Ribavirin—Anxiety—Doxorubicin—urinary bladder cancer	2.88e-05	0.000233	CcSEcCtD
Ribavirin—Paraesthesia—Methotrexate—urinary bladder cancer	2.87e-05	0.000232	CcSEcCtD
Ribavirin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	2.87e-05	0.000232	CcSEcCtD
Ribavirin—ENPP1—Metabolism—PTEN—urinary bladder cancer	2.87e-05	0.000521	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—PTEN—urinary bladder cancer	2.87e-05	0.000521	CbGpPWpGaD
Ribavirin—Discomfort—Doxorubicin—urinary bladder cancer	2.86e-05	0.000231	CcSEcCtD
Ribavirin—Anorexia—Epirubicin—urinary bladder cancer	2.86e-05	0.000231	CcSEcCtD
Ribavirin—Dyspnoea—Methotrexate—urinary bladder cancer	2.85e-05	0.00023	CcSEcCtD
Ribavirin—ENPP1—Disease—MYC—urinary bladder cancer	2.85e-05	0.000517	CbGpPWpGaD
Ribavirin—Somnolence—Methotrexate—urinary bladder cancer	2.85e-05	0.00023	CcSEcCtD
Ribavirin—Dry mouth—Doxorubicin—urinary bladder cancer	2.83e-05	0.000228	CcSEcCtD
Ribavirin—Dyspepsia—Methotrexate—urinary bladder cancer	2.82e-05	0.000228	CcSEcCtD
Ribavirin—Hypotension—Epirubicin—urinary bladder cancer	2.8e-05	0.000226	CcSEcCtD
Ribavirin—Confusional state—Doxorubicin—urinary bladder cancer	2.8e-05	0.000226	CcSEcCtD
Ribavirin—ENPP1—Disease—EGFR—urinary bladder cancer	2.79e-05	0.000506	CbGpPWpGaD
Ribavirin—Decreased appetite—Methotrexate—urinary bladder cancer	2.78e-05	0.000225	CcSEcCtD
Ribavirin—Oedema—Doxorubicin—urinary bladder cancer	2.77e-05	0.000224	CcSEcCtD
Ribavirin—Anaphylactic shock—Doxorubicin—urinary bladder cancer	2.77e-05	0.000224	CcSEcCtD
Ribavirin—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	2.76e-05	0.000223	CcSEcCtD
Ribavirin—Fatigue—Methotrexate—urinary bladder cancer	2.76e-05	0.000223	CcSEcCtD
Ribavirin—Pain—Methotrexate—urinary bladder cancer	2.74e-05	0.000221	CcSEcCtD
Ribavirin—NT5C2—Metabolism—EP300—urinary bladder cancer	2.74e-05	0.000497	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—EP300—urinary bladder cancer	2.74e-05	0.000497	CbGpPWpGaD
Ribavirin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	2.73e-05	0.00022	CcSEcCtD
Ribavirin—Shock—Doxorubicin—urinary bladder cancer	2.73e-05	0.00022	CcSEcCtD
Ribavirin—Nervous system disorder—Doxorubicin—urinary bladder cancer	2.72e-05	0.00022	CcSEcCtD
Ribavirin—Thrombocytopenia—Doxorubicin—urinary bladder cancer	2.71e-05	0.000219	CcSEcCtD
Ribavirin—Insomnia—Epirubicin—urinary bladder cancer	2.71e-05	0.000219	CcSEcCtD
Ribavirin—Tachycardia—Doxorubicin—urinary bladder cancer	2.71e-05	0.000218	CcSEcCtD
Ribavirin—Skin disorder—Doxorubicin—urinary bladder cancer	2.69e-05	0.000217	CcSEcCtD
Ribavirin—Paraesthesia—Epirubicin—urinary bladder cancer	2.69e-05	0.000217	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—PTGS2—urinary bladder cancer	2.68e-05	0.000487	CbGpPWpGaD
Ribavirin—Hyperhidrosis—Doxorubicin—urinary bladder cancer	2.68e-05	0.000216	CcSEcCtD
Ribavirin—Dyspnoea—Epirubicin—urinary bladder cancer	2.67e-05	0.000216	CcSEcCtD
Ribavirin—Somnolence—Epirubicin—urinary bladder cancer	2.66e-05	0.000215	CcSEcCtD
Ribavirin—Anorexia—Doxorubicin—urinary bladder cancer	2.64e-05	0.000213	CcSEcCtD
Ribavirin—Feeling abnormal—Methotrexate—urinary bladder cancer	2.64e-05	0.000213	CcSEcCtD
Ribavirin—Dyspepsia—Epirubicin—urinary bladder cancer	2.64e-05	0.000213	CcSEcCtD
Ribavirin—ENPP1—Disease—KRAS—urinary bladder cancer	2.63e-05	0.000478	CbGpPWpGaD
Ribavirin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	2.62e-05	0.000211	CcSEcCtD
Ribavirin—Decreased appetite—Epirubicin—urinary bladder cancer	2.6e-05	0.00021	CcSEcCtD
Ribavirin—Hypotension—Doxorubicin—urinary bladder cancer	2.59e-05	0.000209	CcSEcCtD
Ribavirin—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	2.59e-05	0.000209	CcSEcCtD
Ribavirin—Fatigue—Epirubicin—urinary bladder cancer	2.58e-05	0.000209	CcSEcCtD
Ribavirin—Constipation—Epirubicin—urinary bladder cancer	2.56e-05	0.000207	CcSEcCtD
Ribavirin—Pain—Epirubicin—urinary bladder cancer	2.56e-05	0.000207	CcSEcCtD
Ribavirin—Urticaria—Methotrexate—urinary bladder cancer	2.54e-05	0.000205	CcSEcCtD
Ribavirin—Abdominal pain—Methotrexate—urinary bladder cancer	2.53e-05	0.000204	CcSEcCtD
Ribavirin—Body temperature increased—Methotrexate—urinary bladder cancer	2.53e-05	0.000204	CcSEcCtD
Ribavirin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	2.53e-05	0.000204	CcSEcCtD
Ribavirin—Insomnia—Doxorubicin—urinary bladder cancer	2.51e-05	0.000202	CcSEcCtD
Ribavirin—ADK—Metabolism—PTGS2—urinary bladder cancer	2.49e-05	0.000453	CbGpPWpGaD
Ribavirin—Paraesthesia—Doxorubicin—urinary bladder cancer	2.49e-05	0.000201	CcSEcCtD
Ribavirin—Dyspnoea—Doxorubicin—urinary bladder cancer	2.47e-05	0.0002	CcSEcCtD
Ribavirin—Feeling abnormal—Epirubicin—urinary bladder cancer	2.47e-05	0.000199	CcSEcCtD
Ribavirin—Somnolence—Doxorubicin—urinary bladder cancer	2.46e-05	0.000199	CcSEcCtD
Ribavirin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	2.45e-05	0.000198	CcSEcCtD
Ribavirin—Dyspepsia—Doxorubicin—urinary bladder cancer	2.44e-05	0.000197	CcSEcCtD
Ribavirin—Decreased appetite—Doxorubicin—urinary bladder cancer	2.41e-05	0.000195	CcSEcCtD
Ribavirin—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	2.39e-05	0.000193	CcSEcCtD
Ribavirin—Fatigue—Doxorubicin—urinary bladder cancer	2.39e-05	0.000193	CcSEcCtD
Ribavirin—Urticaria—Epirubicin—urinary bladder cancer	2.38e-05	0.000192	CcSEcCtD
Ribavirin—Constipation—Doxorubicin—urinary bladder cancer	2.37e-05	0.000191	CcSEcCtD
Ribavirin—Pain—Doxorubicin—urinary bladder cancer	2.37e-05	0.000191	CcSEcCtD
Ribavirin—Abdominal pain—Epirubicin—urinary bladder cancer	2.37e-05	0.000191	CcSEcCtD
Ribavirin—Body temperature increased—Epirubicin—urinary bladder cancer	2.37e-05	0.000191	CcSEcCtD
Ribavirin—Hypersensitivity—Methotrexate—urinary bladder cancer	2.36e-05	0.00019	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—PTEN—urinary bladder cancer	2.34e-05	0.000425	CbGpPWpGaD
Ribavirin—Asthenia—Methotrexate—urinary bladder cancer	2.3e-05	0.000185	CcSEcCtD
Ribavirin—Feeling abnormal—Doxorubicin—urinary bladder cancer	2.28e-05	0.000184	CcSEcCtD
Ribavirin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	2.27e-05	0.000183	CcSEcCtD
Ribavirin—Pruritus—Methotrexate—urinary bladder cancer	2.27e-05	0.000183	CcSEcCtD
Ribavirin—ENPP1—Disease—HRAS—urinary bladder cancer	2.24e-05	0.000406	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—EP300—urinary bladder cancer	2.23e-05	0.000405	CbGpPWpGaD
Ribavirin—Hypersensitivity—Epirubicin—urinary bladder cancer	2.21e-05	0.000178	CcSEcCtD
Ribavirin—Urticaria—Doxorubicin—urinary bladder cancer	2.2e-05	0.000178	CcSEcCtD
Ribavirin—Abdominal pain—Doxorubicin—urinary bladder cancer	2.19e-05	0.000177	CcSEcCtD
Ribavirin—Body temperature increased—Doxorubicin—urinary bladder cancer	2.19e-05	0.000177	CcSEcCtD
Ribavirin—Diarrhoea—Methotrexate—urinary bladder cancer	2.19e-05	0.000177	CcSEcCtD
Ribavirin—ADK—Metabolism—PTEN—urinary bladder cancer	2.17e-05	0.000395	CbGpPWpGaD
Ribavirin—Asthenia—Epirubicin—urinary bladder cancer	2.15e-05	0.000174	CcSEcCtD
Ribavirin—Pruritus—Epirubicin—urinary bladder cancer	2.12e-05	0.000171	CcSEcCtD
Ribavirin—Dizziness—Methotrexate—urinary bladder cancer	2.12e-05	0.000171	CcSEcCtD
Ribavirin—ADK—Metabolism—EP300—urinary bladder cancer	2.07e-05	0.000377	CbGpPWpGaD
Ribavirin—Diarrhoea—Epirubicin—urinary bladder cancer	2.05e-05	0.000166	CcSEcCtD
Ribavirin—Hypersensitivity—Doxorubicin—urinary bladder cancer	2.04e-05	0.000165	CcSEcCtD
Ribavirin—Vomiting—Methotrexate—urinary bladder cancer	2.04e-05	0.000164	CcSEcCtD
Ribavirin—Rash—Methotrexate—urinary bladder cancer	2.02e-05	0.000163	CcSEcCtD
Ribavirin—Dermatitis—Methotrexate—urinary bladder cancer	2.02e-05	0.000163	CcSEcCtD
Ribavirin—Headache—Methotrexate—urinary bladder cancer	2.01e-05	0.000162	CcSEcCtD
Ribavirin—Asthenia—Doxorubicin—urinary bladder cancer	1.99e-05	0.000161	CcSEcCtD
Ribavirin—Dizziness—Epirubicin—urinary bladder cancer	1.98e-05	0.00016	CcSEcCtD
Ribavirin—Pruritus—Doxorubicin—urinary bladder cancer	1.96e-05	0.000158	CcSEcCtD
Ribavirin—Vomiting—Epirubicin—urinary bladder cancer	1.9e-05	0.000154	CcSEcCtD
Ribavirin—Nausea—Methotrexate—urinary bladder cancer	1.9e-05	0.000154	CcSEcCtD
Ribavirin—Diarrhoea—Doxorubicin—urinary bladder cancer	1.9e-05	0.000153	CcSEcCtD
Ribavirin—Rash—Epirubicin—urinary bladder cancer	1.89e-05	0.000153	CcSEcCtD
Ribavirin—Dermatitis—Epirubicin—urinary bladder cancer	1.89e-05	0.000152	CcSEcCtD
Ribavirin—Headache—Epirubicin—urinary bladder cancer	1.88e-05	0.000152	CcSEcCtD
Ribavirin—Dizziness—Doxorubicin—urinary bladder cancer	1.83e-05	0.000148	CcSEcCtD
Ribavirin—Nausea—Epirubicin—urinary bladder cancer	1.78e-05	0.000144	CcSEcCtD
Ribavirin—Vomiting—Doxorubicin—urinary bladder cancer	1.76e-05	0.000142	CcSEcCtD
Ribavirin—Rash—Doxorubicin—urinary bladder cancer	1.75e-05	0.000141	CcSEcCtD
Ribavirin—Dermatitis—Doxorubicin—urinary bladder cancer	1.75e-05	0.000141	CcSEcCtD
Ribavirin—Headache—Doxorubicin—urinary bladder cancer	1.74e-05	0.00014	CcSEcCtD
Ribavirin—Nausea—Doxorubicin—urinary bladder cancer	1.65e-05	0.000133	CcSEcCtD
